Financials
- Market Capitalization 60.85 M
- Employee 31
- Founded 1999
- CEO Mark Erlander
- Website www.cardiffoncology.com
- Headquarter Delaware, United States
- FIGI BBG000PXLKM7
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-2.42
売上高対価格比率
206.41
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4201 | CING Cingulate Inc. - Common Stock | 4.59 USD | -2.55% | -6.33% | -5.94% | -25.49% | 60.94 M USD | ||
| 4204 | EDSA Edesa Biotech, Inc. - Common Shares | 6.87 USD | +1.93% | -6.15% | +9.22% | +209.46% | 61.09 M USD | ||
| 4225 | ELTX Elicio Therapeutics, Inc. - Common Stock | 3.04 USD | -2.25% | -12.64% | -3.49% | -69.60% | 58.02 M USD | ||
| 4230 | CNTX Context Therapeutics Inc. - Common Stock | 0.63 USD | +1.61% | +5.00% | -5.97% | -24.10% | 57.88 M USD |